Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-25-100816
Filing Date
2025-04-28
Accepted
2025-04-28 17:07:30
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d892593d10ka.htm   iXBRL 10-K/A 382748
2 EX-31.3 d892593dex313.htm EX-31.3 3350
3 EX-31.4 d892593dex314.htm EX-31.4 3325
  Complete submission text file 0001193125-25-100816.txt   887469

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA coya-20241231.xsd EX-101.SCH 6136
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE coya-20241231_def.xml EX-101.DEF 18883
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE coya-20241231_lab.xml EX-101.LAB 24962
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coya-20241231_pre.xml EX-101.PRE 20681
21 EXTRACTED XBRL INSTANCE DOCUMENT d892593d10ka_htm.xml XML 67607
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41583 | Film No.: 25881469
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)